Long noncoding RNA dysregulation in ischemic heart failure

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Greco, Simona ^a   Zaccagnini, Germana ^a   Perfetti, Alessandra ^a   Fuschi, Paola ^a   Valaperta, Rea ^a   Voellenkle, Christine ^a   Castelvecchio, Serenella ^a   Gaetano, Carlo ^b   Finato, Nicoletta ^c   Beltrami, Antonio Paolo ^c   Menicanti, Lorenzo ^a   Martelli, Fabio ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b GOETHE UNIVERSITY   (Germany)

^c SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; RNA H19; H19 LONG NON-CODING RNA; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANRIL GENE; ARTICLE; CDKN2B AS1 GENE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EGOT GENE; END STAGE HEART FAILURE; FEMALE; GENE; GENE AND NUCLEIC ACID PARAMETERS; GENE EXPRESSION; H19 GENE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HOTAIR GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART FAILURE; LOC285194 GENE; MALE; MIDDLE AGED; MOUSE; NON END STAGE DILATED ISCHEMIC CARDIOMYOPATHY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RMRP GENE; RNA DYSREGULATION; RNY5 GENE; SOX2 OT GENE; SRA1 GENE; TUSC7 GENE; WNT SIGNALING PATHWAY; AGED; ANIMAL; BLOOD; CARDIOMEGALY; CHRONIC DISEASE; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE ISCHEMIA; METABOLISM; REPRODUCIBILITY;

AGED; ANIMALS; CARDIOMEGALY; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MALE; MICE; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS; RNA, LONG NONCODING; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84975297924     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0926-5     Document Type: Article

References (80)

1. Hunt SA, Abraham WT, Marshall H, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Peter S, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, David P, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA practice guidelines ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation. 2005;112:154-235.
2. Creemers EE, Wilde AA, Pinto YM. Heart failure: advances through genomics. Nat Rev Genet. 2011;12:357-62.
3. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57-74.
4. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15:17-29.
5. Greco S, Gorospe M, Martelli F. Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol. 2015;83:142-55.
6. van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov. 2012;11:860-72.
7. Almeida MI, Reis RM, Calin GA. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011;717:1-8.
8. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220:126-39.
9. Dimmeler S, Marian AJ, Olson E, Thum T, Condorelli G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res. 2015;116:751-63.
10. Papait R, Kunderfranco P, Stirparo GG. Long noncoding rna: a new player of heart failure? J Cardiovasc Transl Res. 2013;6:876-83.
11. Beltrami C, Angelini TG, Emanueli C. Noncoding RNAs in diabetes vascular complications. J Mol Cell Cardiol. 2014;89:1-9.
12. Di Salvo TG, Guo Y, Su YR, Clark T, Brittain E, Absi T, Maltais S, Hemnes A. Right ventricular long noncoding RNA expression in human heart failure. Pulm Circ. 2015;5:135-61.
13. Di Salvo TG, Yang KC, Brittain E, Absi T, Maltais S. Right ventricular myocardial biomarkers in human heart failure. J Card Fail. 2015;21:398-411.
14. Matkovich SJ, Edwards JR, Grossenheider TC, Strong CDG, Ii GWD. Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci. 2014;111:1-6.
15. Devaux Y, Zangrando J, Schroen B, Creemers EE, Pedrazzini T, Chang CP, Dorn GW 2nd, Thum T, Heymans S. Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol. 2015;12:415-25.
16. Ounzain S, Burdet F, Ibberson M, Pedrazzini T. Discovery and functional characterization of cardiovascular long noncoding RNAs. J Mol Cell Cardiol. 2015;89:17-26.
17. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC, Menicanti L, Martelli F. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes. 2012;61:1633-41.
18. Castelvecchio S, Menicanti L, Di Donato M. Surgical ventricular restoration to reverse left ventricular remodeling. Curr Cardiol Rev. 2010;6:15-23.
19. Voellenkle C, van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, Melillo G, Rigolini R, Costa E, Crea F, Capogrossi MC, Napolitano M, Martelli F. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genom. 2010;42:420-6.
20. Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, Litwin SE. Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol. 2003;285:H1261-9.
21. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross JJ. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;94:1109-17.
22. Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, Cardani R, Perbellini R, Isaia E, Sale P, Meola G, Capogrossi MC, Gaetano C, Martelli F. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009;23:3335-46.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402-8.
24. Co-LncRNA [ http://www.bio-bigdata.com/Co-LncRNA/ ].
25. WebGestalt [ http://bioinfo.vanderbilt.edu/webgestalt/ ].
26. UCSC Genome bioinformatics [ https://genome.ucsc.edu/ ].
27. Cappuzzello C, Napolitano M, Arcelli D, Melillo G, Melchionna R, Di Vito L, Carlini D, Silvestri L, Brugaletta S, Liuzzo G, Crea F, Capogrossi MC. Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genom. 2009;38:233-40.
28. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Breton E, Conte JV, Tomaselli G, Garcia JGN, Hare JM, Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JGN, Hare JM, Ye SQ, Edness G, Breton E, Conte JV, Garcia JGN, Hare JM. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genom. 2007;21:299-307.
29. BioVenn [ http://www.cmbi.ru.nl/cdd/biovenn/index.php ].
30. Menzel U. EMT: exact multinomial test: goodness-of-fit test for discrete multivariate data. R package version 1.1. 2013.
31. RefSeq. NCBI reference sequence database [ http://www.ncbi.nlm.nih.gov/refseq/ ].
32. Cugino D, Gianfagna F, Santimone I, de Gaetano G, Donati MB, Iacoviello L, Di Castelnuovo A. Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr Metab Cardiovasc Dis. 2012;22:619-25.
33. Holdt LM, Teupser D. From genotype to phenotype in human atherosclerosis-recent findings. Curr Opin Lipidol. 2013;24:410-8.
34. Lin H-F, Tsai P-C, Lin R-T, Khor G-T, Sheu S-H, Juo SHH. Sex differential genetic effect of chromosome 9p21 on subclinical atherosclerosis. PLoS ONE. 2010;5:e15124.
35. Scheffold T, Kullmann S, Huge A, Binner P, Ochs HR, Schols W, Thale J, Motz W, Hegge FJ, Stellbrink C, Dorsel T, Gulker H, Heuer H, Dinh W, Stoll M, Haltern G. Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry. BMC Cardiovasc Disord. 2011;11:9.
36. Garcia-Menendez L, Karamanlidis G, Kolwicz S, Tian R. Substrain specific response to cardiac pressure overload in C57BL/6 mice. Am J Physiol Heart Circ Physiol. 2013;305:H397-402.
37. Liu Y, Shen Y, Zhu J, Liu M, Li X, Chen Y, Kong X, Song G, Qian L. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice. Cell Physiol Biochem. 2015;35:1975-85.
38. Di Stefano V, Zaccagnini G, Capogrossi MC, Martelli F. MicroRNAs as peripheral blood biomarkers of cardiovascular disease. Vasc Pharmacol. 2011;55:111-8.
39. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90:464-70.
40. Levsky JM, Singer RH. Fluorescence in situ hybridization: past, present and future. J Cell Sci. 2003;116(Pt 14):2833-8.
41. Itzkovitz S, van Oudenaarden A. Validating transcripts with probes and imaging technology. Nat Methods. 2011;8(4 Suppl):S12-9.
42. Bustin SA, Benes V, Nolan T, Pfaffl MW. Quantitative real-time RT-PCR-a perspective. J Mol Endocrinol. 2005;34:597-601.
43. Voellenkle C, Garcia-Manteiga JM, Pedrotti S, Perfetti A, De Toma I, Da Silva D, Maimone B, Greco S, Fasanaro P, Creo P, Zaccagnini G, Gaetano C, Martelli F. Implication of long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep. 2016;6:24141.
44. Berteaux N, Aptel N, Cathala G, Genton C, Coll J, Daccache A, Spruyt N, Hondermarck H, Dugimont T, Curgy J-J, Forne T, Adriaenssens E. A novel H19 antisense RNA overexpressed in breast cancer contributes to paternal IGF2 expression. Mol Cell Biol. 2008;28:6731-45.
45. van Heesch S, van Iterson M, Jacobi J, Boymans S, Essers PB, de Bruijn E, Hao W, MacInnes AW, Cuppen E, Simonis M. Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes. Genome Biol. 2014;15:R6.
46. Greco S, Gorospe M, Martelli F. Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol. 2015;83:142-55.
47. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo Y-Y. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41:4976-87.
48. Chen J, Lui W-O, Vos MD, Clark GJ, Takahashi M, Schoumans J, Khoo SK, Petillo D, Lavery T, Sugimura J, Astuti D, Zhang C, Kagawa S, Maher ER, Larsson C, Alberts AS, Kanayama H, Teh BT. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell. 2003;4:405-13.
49. Ng S, Bogu GK, Soh BS, Stanton LW. The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis. Mol Cell. 2013;51:349-59.
50. Louro R, Smirnova AS, Verjovski-almeida S. Genomics Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics. 2009;93:291-8.
51. Ulitsky I, Bartel DP. LincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26-46.
52. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Biochimica et Biophysica Acta Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. BBA Gen Subj. 2012;1820:940-8.
53. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014;114:345-53.
54. Khatri P, Draghici S. Ontological analysis of gene expression data: current tools, limitations, and open problems. Bioinformatics. 2005;21:3587-95.
55. Marchese FP, Huarte M. Long non-coding RNAs and chromatin modifiers: their place in the epigenetic code. Epigenetics. 2014;9:21-6.
56. Bhan A, Hussain I, Ansari KI, Kasiri S, Bashyal A, Mandal SS. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol Biol. 2013;425:3707-22.
57. Carrion K, Dyo J, Patel V, Sasik R, Mohamed SA, Hardiman G, Nigam V. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/b-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS ONE. 2014;9:1-7.
58. Sano M, Schneider MD. Cyclins that don't cycle-cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle. 2003;2:99-104.
59. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, Bergert H, Schuler G, Thiery J, Teupser D. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arter Thromb Vasc Biol. 2010;30:620-7.
60. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30:1956-62.
61. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou M-M. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010;38:662-74.
62. Pilbrow AP, Folkersen L, Pearson JF, Brown CM, McNoe L, Wang NM, Sweet WE, Tang WHW, Black MA, Troughton RW, Richards AM, FrancoCereceda A, Gabrielsen A, Eriksson P, Moravec CS, Cameron VA. The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues. PLoS ONE. 2012;7:1-11.
63. Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K, Finstermeier K, Stahringer A, Wilfert W, Beutner F, Gielen S, Schuler G, Gabel G, Bergert H, Bechmann I, Stadler PF, Thiery J, Teupser D. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet. 2013;9:e1003588.
64. Scheuermann JC, Boyer LA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO J. 2013;32:1805-16.
65. Cooper C, Vincett D, Yan Y, Hamedani MK, Myal Y, Leygue E. Steroid receptor RNA Activator bi-faceted genetic system: heads or tails? Biochimie. 2011;93:1973-80.
66. Friedrichs F, Zugck C, Rauch G, Friedrichs F, Zugck C, Ivandic B, Weichenhan D, Mu M, Meder B, Eddine N, Mokhtari E, Regitz-zagrosek V, Hetzer R, Scha A, Schreiber S, Chen J, Neuhaus I, Ji R, Siemers NO, Frey N, Rottbauer W, Katus HA, Stoll M. HBEGF, SRA1, and IK: three cosegregating genes as determinants of cardiomyopathy. Genome Res. 2009;19:395-403.
67. Lanz RB, Chua SS, Barron N, So BM, Demayo F, Malley BWO. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003;23:7163-76.
68. Brunkow ME, Tilghman SM. Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev. 1991;5:1092-101.
69. Lee JH, Gao C, Peng G, Greer C, Ren S, Wang Y, Xiao X. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. 2011;109:1332-41.
70. Kim D, Zhang L, Dzau VJ, Pratt RE. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J Clin Invest. 1994;93:355-60.
71. Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, De-Groot N, Hochberg A. Possible physiological role of H19 RNA. Mol Carcinog. 2002;35:63-74.
72. Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-lail R, Fellig Y, Galun E, Hochberg A. Biochimica et Biophysica Acta The oncofetal H19 RNA connection: hypoxia, p53 and cancer. BBA - Mol Cell Res. 2010;1803:443-51.
73. Devlin AM, Bottiglieri T, Domann FE, Lentz SR. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem. 2005;280:25506-11.
74. Li L, Xie J, Zhang M, Wang S. Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. Acta Biochim Biophys Sin (Shanghai). 2009;41:464-71.
75. Gao W, Zhu M, Wang H, Zhao S, Zhao D, Yang Y, Wang Z-M, Wang F, Yang Z-J, Lu X, Wang L-S. Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat Res Mol Mech Mutagen. 2015;772:15-22.
76. Hernandez-Valero MA, Rother J, Gorlov I, Frazier M, Gorlova O. Interplay between polymorphisms and methylation in the H19/IGF2 gene region may contribute to obesity in Mexican-American children. J Dev Orig Health Dis. 2013;4:499-506.
77. Tragante V, Barnes MR, Ganesh SK, Lanktree MB, Guo W, Franceschini N, Smith EN, Johnson T, Holmes MV, Padmanabhan S, Karczewski KJ, Almoguera B, Barnard J, Baumert J, Chang YPC, Elbers CC, Farrall M, Fischer ME, Gaunt TR, Gho JMIH, Gieger C, Goel A, Gong Y, Isaacs A, Kleber ME, Leach IM, McDonough CW, Meijs MFL, Melander O, Nelson CP, et al. Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. Am J Hum Genet. 2014;94:349-60.
78. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med. 2002;32:1102-15.
79. Conklin DJ, Guo Y, Jagatheesan G, Kilfoil PJ, Haberzettl P, Hill BG, Baba SP, Guo L, Wetzelberger K, Obal D, Rokosh DG, Prough RA, Prabhu SD, Velayutham M, Zweier JL, Hoetker JD, Riggs DW, Srivastava S, Bolli R, Bhatnagar A. Genetic deficiency of glutathione S-transferase p increases myocardial sensitivity to ischemia-reperfusion injury. Circ Res. 2015;117:437-49.
80. Takemura G, Miyata S, Kawase Y, Okada H, Maruyama R, Fujiwara H. Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy. 2006;2:212-4.